IMU 0.00% 5.2¢ imugene limited

Well - certainly good news - though not unexpected. The headline...

  1. 2,883 Posts.
    lightbulb Created with Sketch. 12224
    Well - certainly good news - though not unexpected. The headline results are:

    "The two studies, a repeat dose toxicology study in rats and a cardiovascular/respiratory safety pharmacology study in beagle dogs, were conducted under FDA accredited conditions. In both studies, no adverse effects were noted at doses which are higher than those to be used in the Phase Ib trial commencing imminently in 2016.
    Importantly, as a critical marker for the vaccine working as expected, very strong cancer fighting antibodies were measured in the sera of both species."

    It would be nice to get some more information on this. Today's announcement is very bare bones. Hopefully IMU will release a more detailed analysis soon.

    Cheers

    Dave
    Last edited by davybabyk: 20/09/16
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.2¢
Change
0.000(0.00%)
Mkt cap ! $382.1M
Open High Low Value Volume
5.3¢ 5.3¢ 5.2¢ $160.0K 3.048M

Buyers (Bids)

No. Vol. Price($)
23 882045 5.2¢
 

Sellers (Offers)

Price($) Vol. No.
5.3¢ 457736 5
View Market Depth
Last trade - 16.10pm 19/08/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.